Alexander Roediger, Associate Vice-President, Global Lead Oncology Policy at MSD, shared on LinkedIn:
“Early cancer care saves lives.
That simple idea is at the heart of Mission Early, and I was proud to support its Funder Event at ESMO in Madrid last week.
Four years ago, Mission Early started with a simple question: What drives better cancer outcomes?
New treatments are important, but they are only part of the answer. Early detection, timely diagnosis and timely access to high-quality cancer care can be just as critical. When breast cancer is detected early and patients receive timely care, five-year survival can be around 99%.
This became the foundation of Mission Early: Early cancer care saves lives.
Since then, Mission Early has built evidence, engaged European institutions and brought together partners around the world. Today, it is supported by Cancer Patients Europe – CPE, All.Can International, expert advisers and private-sector partners including MSD, with Union for International Cancer Control (UICC) as the secretariat.
And the work is not finished. A few organizations cannot solve this challenge alone. Therefore, we are looking for more partners who share the ambition to improve cancer outcomes through earlier care. Learn more.”
You can also read other articles about cancer care on OncoDaily:
Ruiling Yuan: Health Policy Matters in Advancing Cancer Care
